Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,373.1
15.9 (0.47%)

 

  • STI Straits Times Index
    3,373.1
    15.9 (0.47%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,655.7
    0.3 (0.02%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,466.5
    95.2 (0.34%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,899.9
    13.0 (0.45%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,620.9
    204.1 (0.95%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,403.8
    -29.7 (-0.46%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,101.4
    8.1 (0.39%)
    Index delayed 20 minutes
  • XAO XAO
    6,812.5
    31.3 (0.46%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,090.1M
  • Value: 895.3M
  • Rise: 221
  • Fall: 157
  • Unch: 460

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sinwa0.047+0.016
DISA0.002-
Accrelist0.004+0.002
Singapore-eDev0.051+0.015
Jadason^0.045+0.005
Sino Grandness0.051+0.001
SingTel3.520-
Sen Yue0.039-
Genting Sing0.935+0.010
Tritech0.029-

World Indices

World Indices
Name Last Change
Nasdaq 8,204.1 +57.6
HSI 28,466.5
HSCEI 10,809.9
Jakarta 6,403.8
Nikkei 225 21,620.9
SSE Comp 2,899.9
Shanghai A 3,037.4
Shanghai B 287.4
ShenZhen A 1,616.6
ShenZhen B 967.4
PSE Comp 0.0
KOSPI 2,101.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

FACTOR THERAPEUTICS LIMITED FACTOR THERAPEUTICS LIMITED
Updated on 23 Jul 2019 (End of trading day)
Last (AUD): 0.003 Change: - High: 0.003 Remarks: -
Change (%): - Low: 0.003
Open 0.003 Yesterday's Close 0.003
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) - Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.01051 Trailing EPS (AUD) e -0.01051 NAV (AUD) b 0.0008
PE a - Trailing PE f - Price / NAV b 3.7500
Dividend (AUD) d - Cash In Hand (AUD) g 0.0024 Issued & Paid-up Shares c 1,042,840,000
Dividend Yield (%) d - Price / Cash In Hand g 1.250 Treasury Shares h -
Beta - 75 Daysi -4.105 R-Squared - 75 Days(%)i 7.33 Market Cap (M) 3.129
Beta - 500 Daysi -0.376 R-Squared - 500 Days (%)i 0.06 Enterprise Value (M) 0.518
Piotroski F Score 1 Exchange Code FTT Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 373.76 Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 Feb 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 05 May 2016.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference FACTOR THERAPEUTICS LIMITED ASX 3.129 - - 3.7500 -
Industry Biotechnology ASX 2,040.134 54.649 51.602 13.0413 0.974
Local Peer CSL ASX 101,018.277 45.273 41.466 14.6569 1.022
Local Peer POLYNOVO LIMITED ASX 1,107.322 - - 40.9535 -
Local Peer AVITA MEDICAL LTD ASX 776.590 - - 24.8503 -
Local Peer MESOBLAST LTD ASX 735.313 - - 1.0427 -
Local Peer NEXT SCIENCE LTD ASX 676.572 - - - -
Local Peer STARPHARMA HOLDINGS LIMITED ASX 499.928 - - 10.4344 -
Local Peer TELIX PHARMACEUTIC ASX 337.375 - - 6.3764 -
Local Peer CYNATA THERAPEUTICS LTD ASX 182.374 - - 11.9174 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 144.438 46.996 47.002 5.8553 -
Local Peer RESAPP HEALTH LIMITED ASX 104.438 - - 11.1940 -
Local Peer IMMUTEP LTD ASX 78.740 - - 2.3404 -
Local Peer IMUGENE LIMITED ASX 68.587 - - 2.2093 -
Other Local Peers PHYLOGICA LIMITED (ASX), ORTHOCELL LIMITED (ASX), ZELDA THERAPEUTICS LTD (ASX), BIOTRON (ASX), RHINOMED LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), MEMPHASYS LTD (ASX), ONCOSIL MEDICAL LIMITED (ASX), ADALTA LTD (ASX), PATRYS LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), IMMURON LIMITED (ASX), BIONOMICS LTD (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CELLMID LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), BIOXYNE LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), ACTINOGEN MEDICAL LTD (ASX), CCP TECHNOLOGIES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), MEDIBIO LIMITED (ASX), NANOLLOSE LTD (ASX), BPH ENERGY LIMITED (ASX), ALCHEMIA LIMITED (ASX), GENERA BIOSYSTEMS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 107,281.643 12.781 13.286 9.9042 3.099
Global Peer GILEAD SCIENCES INC NASDAQ 82,536.960 15.131 14.008 3.7601 3.541
Global Peer AMGEN-T HKEx 609,936.000 9.271 9.631 7.1731 4.272
Global Peer CELGENE CORP NASDAQ 63,099.612 15.596 13.298 7.7281 -
Global Peer BIOGEN INC NASDAQ 45,076.245 10.174 9.659 3.2593 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 44,585.544 21.268 20.691 9.4395 -
Global Peer ILLUMINA INC NASDAQ 43,847.160 53.084 51.524 11.0031 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,509.964 13.300 13.392 3.4421 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 27,428.670 353.465 65.871 2.8258 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 21,831.956 69.089 19.545 4.2599 0.868
Other Global Peers INCYTE CORPORATION (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), WUXI BIO (HKEx), SEATTLE GENETICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ARRAY BIOPHARMA INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BEIGENE (HKEx), EXELIXIS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MODERNA INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), GENSCRIPT BIO (HKEx), 3SBIO (HKEx), FIBROGEN INC (NASDAQ), TILRAY INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALKERMES PLC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), LIGAND PHARMACEUTICAL INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), REGENXBIO INC (NASDAQ), NATERA INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), OPKO HEALTH INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INTREXON CORP (NASDAQ), EPIZYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), HAOHAI BIOTEC (HKEx), VOYAGER THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), RETROPHIN INC (NASDAQ), FRONTAGE (HKEx), NGM BIOPHARMACEUTICALS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), VIVA BIOTECH (HKEx), KURA ONCOLOGY INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), ASCLETIS-B (HKEx), SPECTRUM PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), MYOVANT SCIENCES LTD (NYSE), STOKE THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), MACROGENICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AVROBIO INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), SYNTHORX INC (NASDAQ), CKLIFE SCIENCES (HKEx), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ESSEX BIO-TECH (HKEx), MAGENTA THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TRANSLATE BIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DERMIRA INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PROTHENA CORP PLC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), LEE'S PHARM (HKEx), ACHILLION PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), AVID BIOSERVICES INC (NASDAQ), IMMUNOGEN INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), KADMON HLDGS INC (NYSE), AGENUS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), DPHARMA (Bursa), CALITHERA BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), GERON CORP (NASDAQ), ATHERSYS INC (NASDAQ), SYNLOGIC INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), COMPUGEN (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MANNKIND CORPORATION (NASDAQ), CHIASMA INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), MERSANA THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), AFFIMED N V (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), STANDARD DIVERSIFIED INC (NYSE American), ENZO BIOCHEM INC (NYSE), XOMA CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ARDELYX INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), CUE BIOPHARMA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), BBI LIFE SCI (HKEx), PFENEX INC (NYSE American), JOUNCE THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IMV INC (NASDAQ), TOCAGEN INC (NASDAQ), BIOTIME INC (NYSE American), NANTKWEST INC (NASDAQ), SESEN BIO INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), UNI-BIO GROUP (HKEx), PARATEK PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), NOVAVAX INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), INMUNE BIO INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VERASTEM INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), HEMISPHERX BIOPHARMA INC (NYSE American), SAVARA INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), PORT (SET), GENOCEA BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADS EACH REPR 1 ORD SHARE (NASDAQ), OTONOMY INC (NASDAQ), INFLARX N V (NASDAQ), VERMILLION INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), IBIO INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), COHBAR INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ARAVIVE INC (NASDAQ), AQUINOX PHARMACEUTICALS INC (NASDAQ), CEL-SCI CORP (NYSE American), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), CT ENTERPRISE (HKEx), REGENT PACIFIC (HKEx), OPIANT PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), IVERIC BIO INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), EVOGENE LTD (NASDAQ), CONTRAFECT CORP (NASDAQ), SENESTECH INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SOPHIRIS BIO INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), EXTRAWELL PHAR (HKEx), BIONANO GENOMICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), AEVI GENOMIC MEDIC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ORAGENICS INC (NYSE American), MICROBOT MEDICAL INC (NASDAQ), SOLIGENIX INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ISORAY INC (NYSE American), REXAHN PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), BIOCEPT INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), HISTOGENICS CORP (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VICAL INC (NASDAQ), NANOVIRICIDES INC (NYSE American), ONCONOVA THERAPEUTICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ATYR PHARMA INC (NASDAQ), VAXART INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADR EA REPR 150 ORD(POST SPLIT) (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TROVAGENE INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), Suntar Eco-City^ (SGX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ARCA BIOPHARMA INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADR EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), QT Vascular (SGX), PROTEON THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), HAO WEN HLDGS (HKEx), ADVAXIS INC (NASDAQ), MGRC (Bursa), MEGASUN (Bursa), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), OPGEN INC (NASDAQ), NEURALSTEM INC (NASDAQ), CYTORI THERAPEUTICS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.001
-25.00 %
10 Days --0.001
-25.00 %
20 Days --0.001
-25.00 %
Medium Term Return 3 Months --0.001
-25.00 %
6 Months ---
1 Year --0.052
-94.55 %
Long Term Return 2 Years --0.060
-95.24 %
3 Years --0.040
-93.02 %
Annualised Return Annualised --
-58.83 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.002 - 0.093 Change From 1 Year Low +0.001 % Change From 1 Year Low (%) +50.00
Change From 1 Year High -0.090 % Change From 1 Year High (%) -96.77
2 Years Range 0.002 - 0.093 Change From 2 Years Low +0.001 % Change From 2 Years Low (%) +50.00
Change From 2 Years High -0.090 % Change From 2 Years High (%) -96.77
5 Years Range 0.002 - 0.093 Change From 5 Years Low +0.001 % Change From 5 Years Low (%) +50.00
Change From 5 Years High -0.090 % Change From 5 Years High (%) -96.77
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Factor Therapeutics Ltd. engages in biotechnology and pharmaceutical businesses. It involves in the development and commercialization of wound care therapeutics. It offers treatment for venous leg ulcers and diabetic foot ulcers. The company was founded on September 6, 2002 and is headquartered in Brisbane, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
23 Jul 2019 0.003 0.003 0.003 0.003 - -
22 Jul 2019 0.003 0.003 0.003 0.003 - -
19 Jul 2019 0.003 0.003 0.003 0.003 6,120,887 -
18 Jul 2019 0.004 0.004 0.004 0.004 - -
17 Jul 2019 0.004 0.004 0.004 0.004 - -
16 Jul 2019 0.003 0.003 0.003 0.004 100,000 -
15 Jul 2019 0.003 0.003 0.003 0.003 - -
12 Jul 2019 0.003 0.003 0.003 0.003 417,189 -
11 Jul 2019 0.003 0.003 0.003 0.003 36,136,670 -
10 Jul 2019 0.004 0.004 0.004 0.004 1,000,000 -
09 Jul 2019 0.004 0.004 0.004 0.004 21,134,840 -
08 Jul 2019 0.004 0.004 0.004 0.004 16,500 -
05 Jul 2019 0.004 0.004 0.004 0.004 1,515,000 -
04 Jul 2019 0.004 0.004 0.004 0.004 - -
03 Jul 2019 0.004 0.004 0.004 0.004 - -
02 Jul 2019 0.004 0.004 0.004 0.004 15,000 -
01 Jul 2019 0.004 0.004 0.004 0.004 - -
28 Jun 2019 0.004 0.004 0.004 0.004 1,331,633 -
27 Jun 2019 0.004 0.004 0.004 0.004 1,202,020 -
26 Jun 2019 0.004 0.004 0.004 0.004 500,000 -
25 Jun 2019 0.004 0.004 0.004 0.004 1,086,701 -
24 Jun 2019 0.005 0.005 0.004 0.005 569,450 -
Summary
Current 2 Weeks
(10 Jul 2019 to 23 Jul 2019)
0.004 0.004 0.003 0.003 43,774,746 -
Previous 2 Weeks
(26 Jun 2019 to 09 Jul 2019)
0.004 0.004 0.003 0.004 25,714,993 -
4 Weeks from
(28 May 2019 to 25 Jun 2019)
0.006 0.006 0.003 0.004 24,877,484 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.